Showing results (41-50 of 71) with videos related to

Sort By:
Pageof 8
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 31, 2020
ESTRO ACROP guidelines for target volume definition in pancreatic cancerThomas B Brunner, Karin Haustermans, Florence Huguet, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 14, 2016
Conformity analysis to demonstrate reproducibility of target volumes for Margin-Intense Stereotactic Radiotherapy for borderline-resectable pancreatic cancerDaniel L P Holyoake, Maxwell Robinson, Derek Grose, et al.
Radiation Oncology (London, England)|June 14, 2020
A phase 1 trial of the safety, tolerability and biological effects of intravenous Enadenotucirev, a novel oncolytic virus, in combination with chemoradiotherapy in locally advanced rectal cancer (CEDAR)Séan M O'Cathail, Steven Davis, Jane Holmes, et al.
Clinical and Translational Radiation Oncology|November 23, 2019
A systematic review of health economic evaluations of proton beam therapy for adult cancer: Appraising methodology and qualityDavid A Jones, Joel Smith, Xue W Mei, et al.
Radiation Oncology (London, England)|June 4, 2021
Cardiac-sparing radiotherapy for locally advanced non-small cell lung cancerLouise Turtle, Neeraj Bhalla, Andrew Willett, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 15, 2016
Preclinical testing of an Atr inhibitor demonstrates improved response to standard therapies for esophageal cancerKatarzyna B Leszczynska, Greg Dobrynin, Rhea E Leslie, et al.
Cancers|February 25, 2022
Quantitative Analysis of Radiation-Associated Parenchymal Lung ChangeEdward Chandy, Adam Szmul, Alkisti Stavropoulou, et al.
The Lancet. Oncology|January 2, 2013
Stereotactic body radiotherapy for oligometastasesAlison C Tree, Vincent S Khoo, Rosalind A Eeles, et al.
Clinical and Translational Radiation Oncology|March 27, 2020
Oxygen-enhanced MRI MOLLI T1 mapping during chemoradiotherapy in anal squamous cell carcinomaEmma Bluemke, Daniel Bulte, Ambre Bertrand, et al.
Eclinicalmedicine|December 25, 2024
International consensus to define outcomes for trials of chemoradiotherapy for anal cancer (CORMAC-2): defining the outcomes from the CORMAC core outcome setRobert Samuel, Stephen R Knight, Richard Adams, et al.
Pageof 8